InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

OmniAb, Inc.

OABI Clue Score25
United States Fiscal year ends December CIK 0001846253
$4.79 +2.79% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.79 −6.63% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 2 Nov 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue34.7Operating income−35.6Net income−27.0EPS, diluted−0.33Fiscal year 2022Revenue59.1 +70.0%Operating income−26.6Net income−22.3EPS, diluted−0.26Fiscal year 2023Revenue34.2 −42.2%Operating income−69.4Net income−50.6EPS, diluted−0.51Fiscal year 2024Revenue26.4 −22.8%Operating income−74.5Net income−62.0EPS, diluted−0.61Fiscal year 2025Revenue18.7 −29.3%Operating income−69.0Net income−64.8EPS, diluted−0.57
FY2021FY2022FY2023FY2024FY2025
Revenue 34.7 59.1 34.2 26.4 18.7
Growth +70.0% −42.2% −22.8% −29.3%
Operating income −35.6 −26.6 −69.4 −74.5 −69.0
Net income −27.0 −22.3 −50.6 −62.0 −64.8
Growth
EPS, diluted −0.33 −0.26 −0.51 −0.61 −0.57
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Operating margin−102.5%Net margin−77.8%Free cash flow margin−28.0%Fiscal year 2022Operating margin−45.1%Net margin−37.8%Free cash flow margin−35.1%Fiscal year 2023Operating margin−203.2%Net margin−148.2%Free cash flow margin2.1%Fiscal year 2024Operating margin−282.3%Net margin−235.1%Free cash flow margin−157.4%Fiscal year 2025Operating margin−369.5%Net margin−347.0%Free cash flow margin−198.3%
FY2021FY2022FY2023FY2024FY2025
Operating margin −102.5% −45.1% −203.2% −282.3% −369.5%
Net margin −77.8% −37.8% −148.2% −235.1% −347.0%
Free cash flow margin −28.0% −35.1% 2.1% −157.4% −198.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−5.7Capital expenditure−4.1Free cash flow−9.7Fiscal year 2022Operating cash flow−3.6Capital expenditure−17.2Free cash flow−20.8Fiscal year 2023Operating cash flow2.3Capital expenditure−1.6Free cash flow0.7Fiscal year 2024Operating cash flow−39.7Capital expenditure−1.9Free cash flow−41.5 −6,008.8%Fiscal year 2025Operating cash flow−36.5Capital expenditure−0.6Free cash flow−37.0
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.7 −3.6 2.3 −39.7 −36.5
Capital expenditure −4.1 −17.2 −1.6 −1.9 −0.6
Free cash flow −9.7 −20.8 0.7 −41.5 −37.0
Growth −6,008.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash0.0Shareholders’ equity234.3Fiscal year 2022Cash33.4Shareholders’ equity341.4Fiscal year 2023Cash16.4Shareholders’ equity314.6Fiscal year 2024Cash27.6Shareholders’ equity287.6Fiscal year 2025Cash25.5Shareholders’ equity267.0
FY2021FY2022FY2023FY2024FY2025
Cash 0.0 33.4 16.4 27.6 25.5
Shareholders’ equity 234.3 341.4 314.6 287.6 267.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
0.0 33.4 16.4 27.6 25.5
21.1 30.3 3.8 5.3 7.4
n/a n/a n/a 0.0 0.8
6.8 20.0 18.2 15.5 9.4
84.0 84.0 84.0 84.0 84.0
304.5 421.2 375.2 325.6 300.9
Growth +38.3% −10.9% −13.2% −7.6%
Liabilities
70.2 79.8 60.6 37.9 33.9
Equity
0.0 11.3 −39.4 −101.4 −166.2
234.3 341.4 314.6 287.6 267.0
Growth +45.7% −7.8% −8.6% −7.2%
Per share and net cash
0.0 115.2 116.9 121.6 144.3
calc n/a 2.96 2.69 2.37 1.85

Lines marked calc are worked out here from filed figures; point at one for how.